Company news

Opthea Limited news in 2018

Opthea Limited's news releases, calls and decks from 2018, newest first.

View company

Opthea Options Exercise Generates Proceeds of A$13.3m

November 28, 2018

Opthea confirms final patient enrolment in Ph2b wAMD trial

November 25, 2018

Opthea Phase 2b wAMD trial fully recruited ahead of schedule

November 13, 2018

Opthea Receives A$12m R&D Tax Incentive

October 30, 2018

Opthea CEO Presentation of Trial Updates at OIS@AAO 2018

October 25, 2018

Opthea Doses First Patients in Australia for Phase 2a in DME

September 16, 2018

Opthea presents Ph1/2a wAMD data at Retina Society Meeting

September 13, 2018

Opthea Receives Positive Safety Review for Ph2b wAMD Trial

September 4, 2018

Opthea Appendix 4E and Annual Report 2018

August 27, 2018

Opthea Doses First Patient in Ph2a Trial for OPT-302 in DME

July 29, 2018

Opthea Meets Primary Safety Objective in DME Phase 1b trial

July 25, 2018

Opthea reaches mid-way in recruitment for Ph2b wAMD trial

July 1, 2018

Opthea Doses wAMD Patients in Europe and Israel

March 26, 2018

Opthea Receives A$2.7m R&D Tax Incentive

January 7, 2018

Opthea Initiates OPT-302 Diabetic Macular Edema Trial

January 2, 2018

Decks in 2018